317 related articles for article (PubMed ID: 19645172)
21. A novel approach to reversal of neuromuscular blockade.
Della Rocca G; Pompei L
Minerva Anestesiol; 2009 May; 75(5):349-51. PubMed ID: 19412157
[TBL] [Abstract][Full Text] [Related]
22. Clinical pharmacology and efficacy of sugammadex in the reversal of neuromuscular blockade.
Schaller SJ; Lewald H
Expert Opin Drug Metab Toxicol; 2016 Sep; 12(9):1097-108. PubMed ID: 27463265
[TBL] [Abstract][Full Text] [Related]
23. Effective reversal of moderate rocuronium- or vecuronium-induced neuromuscular block with sugammadex, a selective relaxant binding agent.
Suy K; Morias K; Cammu G; Hans P; van Duijnhoven WG; Heeringa M; Demeyer I
Anesthesiology; 2007 Feb; 106(2):283-8. PubMed ID: 17264722
[TBL] [Abstract][Full Text] [Related]
24. Safety and tolerability of single intravenous doses of sugammadex administered simultaneously with rocuronium or vecuronium in healthy volunteers.
Cammu G; De Kam PJ; Demeyer I; Decoopman M; Peeters PA; Smeets JM; Foubert L
Br J Anaesth; 2008 Mar; 100(3):373-9. PubMed ID: 18238834
[TBL] [Abstract][Full Text] [Related]
25. Sugammadex reversal of rocuronium-induced neuromuscular blockade: a comparison with neostigmine-glycopyrrolate and edrophonium-atropine.
Sacan O; White PF; Tufanogullari B; Klein K
Anesth Analg; 2007 Mar; 104(3):569-74. PubMed ID: 17312210
[TBL] [Abstract][Full Text] [Related]
26. Reversal of rocuronium-induced profound neuromuscular block by sugammadex in Duchenne muscular dystrophy.
de Boer HD; van Esmond J; Booij LH; Driessen JJ
Paediatr Anaesth; 2009 Dec; 19(12):1226-8. PubMed ID: 19863737
[TBL] [Abstract][Full Text] [Related]
27. The effect of residual neuromuscular blockade on the speed of reversal with sugammadex.
White PF; Tufanogullari B; Sacan O; Pavlin EG; Viegas OJ; Minkowitz HS; Hudson ME
Anesth Analg; 2009 Mar; 108(3):846-51. PubMed ID: 19224792
[TBL] [Abstract][Full Text] [Related]
28. Early reversal of profound rocuronium-induced neuromuscular blockade by sugammadex in a randomized multicenter study: efficacy, safety, and pharmacokinetics.
Sparr HJ; Vermeyen KM; Beaufort AM; Rietbergen H; Proost JH; Saldien V; Velik-Salchner C; Wierda JM
Anesthesiology; 2007 May; 106(5):935-43. PubMed ID: 17457124
[TBL] [Abstract][Full Text] [Related]
29. [Sugammadex, a revolutionary new drug to reverse neuromuscular block].
Alvarez Gómez JA
Rev Esp Anestesiol Reanim; 2007 Apr; 54(4):205-7. PubMed ID: 17518169
[No Abstract] [Full Text] [Related]
30. Sugammadex: a selective relaxant binding agent for reversal of neuromuscular block.
Hogg RM; Mirakhur RK
Expert Rev Neurother; 2009 May; 9(5):599-608. PubMed ID: 19402771
[TBL] [Abstract][Full Text] [Related]
31. Efficacy, safety, and pharmacokinetics of sugammadex for the reversal of rocuronium-induced neuromuscular blockade in elderly patients.
McDonagh DL; Benedict PE; Kovac AL; Drover DR; Brister NW; Morte JB; Monk TG
Anesthesiology; 2011 Feb; 114(2):318-29. PubMed ID: 21239968
[TBL] [Abstract][Full Text] [Related]
32. Sugammadex--a short review and clinical recommendations for the cardiac anesthesiologist.
Hemmerling TM; Zaouter C; Geldner G; Nauheimer D
Ann Card Anaesth; 2010; 13(3):206-16. PubMed ID: 20826961
[TBL] [Abstract][Full Text] [Related]
33. Sugammadex in clinical practice.
Mirakhur RK
Anaesthesia; 2009 Mar; 64 Suppl 1():45-54. PubMed ID: 19222431
[TBL] [Abstract][Full Text] [Related]
34. Reversal of rocuronium-induced neuromuscular blockade with sugammadex compared with neostigmine during sevoflurane anaesthesia: results of a randomised, controlled trial.
Blobner M; Eriksson LI; Scholz J; Motsch J; Della Rocca G; Prins ME
Eur J Anaesthesiol; 2010 Oct; 27(10):874-81. PubMed ID: 20683334
[TBL] [Abstract][Full Text] [Related]
35. Sugammadex in anesthesia practice.
Duvaldestin P; Plaud B
Expert Opin Pharmacother; 2010 Nov; 11(16):2759-71. PubMed ID: 20977408
[TBL] [Abstract][Full Text] [Related]
36. Worldwide experience with sugammadex sodium: implications for the United States.
Welliver M; Cheek D; Osterbrink J; McDonough J
AANA J; 2015 Apr; 83(2):107-15. PubMed ID: 26016169
[TBL] [Abstract][Full Text] [Related]
37. The use of sugammadex in a patient with myasthenia gravis.
Unterbuchner C; Fink H; Blobner M
Anaesthesia; 2010 Mar; 65(3):302-5. PubMed ID: 20105151
[TBL] [Abstract][Full Text] [Related]
38. [Sugammadex. New pharmacological concept for antagonizing rocuronium and vecuronium].
Sparr HJ; Booij LH; Fuchs-Buder T
Anaesthesist; 2009 Jan; 58(1):66-80. PubMed ID: 19082568
[TBL] [Abstract][Full Text] [Related]
39. A randomised controlled trial comparing sugammadex and neostigmine at different depths of neuromuscular blockade in patients undergoing laparoscopic surgery.
Geldner G; Niskanen M; Laurila P; Mizikov V; Hübler M; Beck G; Rietbergen H; Nicolayenko E
Anaesthesia; 2012 Sep; 67(9):991-8. PubMed ID: 22698066
[TBL] [Abstract][Full Text] [Related]
40. Sugammadex: A Review of Neuromuscular Blockade Reversal.
Keating GM
Drugs; 2016 Jul; 76(10):1041-52. PubMed ID: 27324403
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
